Donidalorsen significantly lowers rate of angioedema attacks in hereditary angioedema patients: NEJM Medical Dialogues Editorial Team30 March 2022 9:00 AM ISTUSA: Donidalorsen therapy resulted in a considerably reduced risk of angioedema attacks than placebo in patients with hereditary angioedema, says an...
Baricitinib effects hair regrowth in severe Alopecia Areata: NEJM MD Editorial Team29 March 2022 11:00 AM ISTAlopecia areata is a known autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are...
Iberdomide found effective in SLE in higher doses compared to placebo: NEJM Medical Dialogues Editorial Team29 March 2022 9:30 AM ISTUSA: Iberdomide was found effective in achieving study endpoints in SLE patients in higher doses compared to placebo in a new study. The study found...
Hydrocortisone no solution to Preterm Babies with Bronchopulmonary Dysplasia: NEJM MD Bureau26 March 2022 12:00 AM ISTBronchopulmonary dysplasia (BPD) remains a leading morbidity of the extremely preterm infant, and prolonged mechanical ventilation is associated with...
Single Dose Liposomal Amphotericin B works for HIV associated Cryptococcal Meningitis MD Bureau25 March 2022 9:15 AM ISTCryptococcal meningitis is the most frequent cause of adult meningitis in areas with a high prevalence of human immunodeficiency virus (HIV) and is...
FDA approves new immunotherapy regimen for patients with melanoma Hina Zahid24 March 2022 8:51 PM ISTThe U.S. Food and Drug Administration has approved a novel therapy for patients with metastatic or inoperable melanoma, an aggressive type of skin...
Intensive Anti-seizure Therapy Might Not Benefit Comatose Survivors of Cardiac Arrest MD Bureau12 March 2022 10:00 AM ISTRhythmic and periodic electroencephalographic (EEG) patterns that may reflect electrographic seizures have been reported in 10 to 35% of comatose...
Treatment length for children with tuberculosis now reduced: Research Medical Dialogues Bureau11 March 2022 12:02 PM ISTWashington: A recent UCL-led international trial that explored tuberculosis (TB) treatment effectiveness in children has led to a change in the World...
Darolutamide added to existing combination therapy in metastatic prostate cancer increases survival, NEJM says Medical Dialogues Editorial Team22 Feb 2022 9:00 AM ISTIn a new trial overall survival was remarkably longer with the combination of darolutamide, androgen-deprivation therapy, and docetaxel than with...
Cemiplimab significantly increases survival in recurrent cervical cancer: NEJM Medical Dialogues Editorial Team14 Feb 2022 9:30 AM ISTPatients with recurrent cervical cancer after first-line platinum-containing chemotherapy lived considerably longer with cemiplimab than with...
Endovascular Therapy Might Benefit Stroke Patients with Large Ischemic Region MD Bureau11 Feb 2022 9:00 AM ISTEndovascular therapy (ET) for acute ischemic stroke is now broadly recognized as one of the most powerful treatments. A recent study suggests that...
Secondary antibiotic prophylaxis reduces risk of rheumatic heart disease progression: Study Dr. Shravani Dali11 Feb 2022 9:00 AM ISTSecondary antibiotic prophylaxis reduces the risk of rheumatic heart disease progression, according to a new study published in the New England...
